9999999995-20-002541.txt : 20200924 9999999995-20-002541.hdr.sgml : 20200924 20200924001511 ACCESSION NUMBER: 9999999995-20-002541 CONFORMED SUBMISSION TYPE: EFFECT PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20200923 DATE AS OF CHANGE: 20200924 EFFECTIVENESS DATE: 20200923 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Taysha Gene Therapies, Inc. CENTRAL INDEX KEY: 0001806310 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 843199512 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: EFFECT SEC ACT: 1933 Act SEC FILE NUMBER: 333-248559 FILM NUMBER: 201193428 BUSINESS ADDRESS: STREET 1: 7318 MORTON STREET CITY: DALLAS STATE: TX ZIP: 75209 BUSINESS PHONE: 212.551.8702 MAIL ADDRESS: STREET 1: 7318 MORTON STREET CITY: DALLAS STATE: TX ZIP: 75209 EFFECT 1 primary_doc.xml X0101 EFFECT 33 LIVE 2020-09-23 16:00:00

S-1

0001806310 Taysha Gene Therapies, Inc. 333-248559